Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.23.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Revenue $ 12,432,146 $ 12,235,986
Costs and Expenses    
Selling expenses 9,868,154 9,286,232
General and administrative expenses 4,447,747 4,570,426
Depreciation and amortization 347,323 438,958
Total Costs and Expenses 14,663,224 14,295,616
Loss from Operations (2,231,078) (2,059,630)
Other (Expenses) Income    
Interest expense, net (35,936) (3,859)
Amortization of debt discount (17,560)
Other income 8,846 39,749
Changes in Fair Value of contingent purchase consideration (450,013)
Other expense (9,028) (1,070)
(Loss) gain on marketable securities (19,000) 77,500
Total Other (Expenses) Income (72,678) (337,693)
Loss Before Income Taxes (2,303,756) (2,397,323)
Income tax provision 10,395 (156,893)
Net Loss (2,293,361) (2,554,216)
Other Comprehensive Income (Loss)    
Foreign currency translation adjustment 87,647 (151,775)
Comprehensive Loss $ (2,205,714) $ (2,705,991)
Loss per common share – basic and diluted $ (0.07) $ (0.11)
Weighted average number of common shares outstanding – basic and diluted 32,495,019 23,515,154